ALBUQUERQUE – April 4, 2017 – Lovelace Medical Center has entered into an employment agreement with Hematology Oncology Associates of New Mexico to employ all providers and staff as part of the Lovelace Cancer Center.
ALBUQUERQUE – April 3, 2017 – Steven Henao, M.D., chief vascular surgeon of New Mexico Heart Institute performed the first implant of the Ovation Alto™ Abdominal Stent Graft system in a patient on Thursday, March 30 at Heart Hospital of New Mexico at Lovelace Medical Center.
The Ovation Alto is manufactured by Endologix Corporation and is designed to treat abdominal aortic aneurysm (AAA).
Lovelace Medical Group opened the new Lovelace Neurosciences Center at 500 Walter St. NE, Suite 401 on March 20. Steven Sinovic at the Albuquerque Journal interviewed John Cruickshank, D.O., CEO of Lovelace Medical Group, regarding the new clinic and what it means for patients to have neurosurgeons, neurologists and other providers in close proximity.
In January, 2017, Lovelace Medical Group opened a new clinic in the Las Estancias development of Albuquerque's South Valley. The new location is becoming a hub of economic development in the area, as reported by The Albuquerque Journal's Steve Sinovic.
ALBUQUERQUE – March 8, 2017 – Physicians at Heart Hospital of New Mexico at Lovelace Medical Center recently implanted the WATCHMAN™ Left Atrial Appendage Closure (LAAC) device in a New Mexico patient.
The device offers patients with non-valvular atrial fibrillation (AF) an alternative to long-term Warfarin blood-thinning medication.
ALBUQUERQUE – March 3, 2017 – Lovelace Westside Hospital was named to Becker’s Hospital Review’s “150 Top Places to Work in Healthcare 2017” list.
The hospital was recognized for encouraging professional development among employees and promoting tomorrow’s leaders. Lovelace Westside Hospital has a history of recognizing employees and offering competitive benefits.
ALBUQUERQUE – February 27, 2017 – Lovelace Medical Group has announced its largest clinic was recently recognized as a Level 1 Patient-Centered Medical Home (PCMH) by the National Committee for Quality Assurance (NCQA). The recognition puts the Lovelace Medical Group on the map as a beacon of high-quality care and service to patients.
ALBUQUERQUE – February 20, 2017 – Lovelace Medical Center has been awarded a three-year term of accreditation in radiation oncology as the result of a recent review by the American College of Radiology (ACR).
This accreditation represents the highest level of quality and patient safety in radiation oncology and is awarded only to facilities meeting specific practice guidelines and technical standards.